Safeguard scientifics inc (SFE)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Changes in assets and liabilities:
Net cash used in operating activities

-16,739

-19,970

-25,929

-24,603

-25,043

-26,035

-23,939

-23,011

-21,038

-20,805

-20,062

-19,225

-19,362

-18,661

-17,777

-17,347

-17,108

-17,749

-18,800

-18,656

-18,854

-20,189

-20,397

-22,459

-22,146

-21,221

-20,208

-18,441

-16,722

-16,525

-16,759

-16,959

-17,136

-17,727

0

0

0

Cash Flows from Investing Activities:
Proceeds from sales of and distributions from ownership interests

63,232

104,302

98,665

151,799

105,908

67,387

69,912

15,054

4,108

16,604

16,715

17,603

85,524

73,965

73,883

86,503

27,060

25,058

26,225

12,998

7,827

82,822

117,997

118,774

114,818

38,974

5,673

7,938

18,862

17,596

14,627

44,338

171,250

171,268

0

0

0

Acquisitions of ownership interest

0

-

-

-

-

-

-

-

-

15,101

29,441

32,128

39,834

52,431

52,846

57,970

73,130

70,186

56,701

74,615

68,244

59,476

68,076

52,113

37,413

41,838

53,099

45,041

39,825

46,100

32,356

42,411

87,317

85,329

0

0

0

Advances and loans

2,371

5,055

5,960

9,773

12,993

13,104

18,032

17,252

20,474

22,867

27,159

31,380

27,277

27,967

22,014

14,424

13,989

15,208

12,035

14,285

18,778

10,968

10,982

9,982

5,876

10,464

9,700

16,624

15,710

13,665

0

0

0

-

-

-

-

Repayment of advances and loans

-

-

-

-

-

10,730

10,652

10,500

10,500

0

0

1,685

1,713

1,741

1,769

1,319

1,318

1,318

465

642

2,750

4,684

6,116

4,820

3,613

1,651

1,044

998

820

3,214

0

0

0

-

-

-

-

Origination fees on mezzanine loans

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

Purchases of marketable securities

-

57,243

70,194

95,052

95,052

37,809

0

0

0

-

-

-

-

-

-

-

-

29,755

34,891

48,483

48,531

55,594

67,389

63,844

64,772

69,883

79,219

129,939

218,054

242,023

290,211

311,975

230,212

240,367

0

0

0

Proceeds from sales and maturities in marketable securities

-

95,189

99,126

74,566

68,973

8,148

5,180

4,740

2,379

11,237

21,197

26,326

29,981

46,315

40,983

47,221

51,427

33,640

43,474

37,642

45,311

55,410

75,694

107,271

131,388

165,379

179,923

235,193

253,679

276,392

268,220

189,077

164,530

108,393

0

0

0

Capital expenditures

-

-

-

-

-

-

-

-

-

-

-

-

-

432

1,527

1,685

1,768

1,856

450

292

158

59

11

27

34

37

85

69

80

73

0

0

0

-

-

-

-

Proceeds from sale of discontinued operations, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Other, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-137

6,387

6,387

-47

-42

0

0

0

-

-

-

-

-107

0

0

0

Net cash (used in) provided by investing activities

81,925

126,303

112,215

112,771

63,817

32,103

36,355

5,717

-14,112

-10,127

-21,444

-24,779

28,567

20,061

15,635

33,368

-29,500

-56,989

-33,781

-86,261

-79,691

16,956

53,354

104,904

148,205

90,258

58,714

66,661

7,421

3,116

-58,212

-128,838

10,965

-52,575

0

0

0

Cash Flows from Financing Activities:
Repurchase of convertible senior debentures

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

30,848

0

0

0

Issuance of Company common stock, net

-

-

-

-

-

-

-

-

-

-

12

17

15

5

5

127

127

676

1,353

1,265

1,316

1,289

632

4,898

4,847

4,417

4,573

1,323

1,697

1,744

1,881

1,085

913

918

0

0

0

Tax withholdings related to equity-based awards

98

236

243

247

266

267

282

293

273

223

198

235

560

460

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repurchase of Company common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

5,389

8,638

10,386

10,442

4,997

1,748

0

16,996

25,036

25,158

25,158

8,162

122

0

0

0

-

-

-

-

-

-

-

-

Net cash used in financing activities

-89,345

-89,483

-85,244

-40,704

-24,951

-24,952

-8,547

-11,217

29,565

29,625

29,663

32,290

-489

-5,844

-9,070

-10,614

-10,315

-4,321

-395

1,265

-16,121

-24,188

-24,967

-20,701

-3,358

4,252

-963

-4,213

-3,796

-3,749

1,881

1,085

913

-29,930

0

0

0

Net change in cash, cash equivalents and restricted cash

-24,159

16,850

1,042

47,464

13,823

-18,884

3,869

-28,511

-5,585

-1,307

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net change in cash, cash equivalents and restricted cash equivalents

-24,159

16,850

1,042

47,464

13,823

-18,884

3,869

-28,511

-5,585

-1,307

-11,843

-11,714

8,716

-4,444

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net change in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

7,990

61,744

122,701

73,289

37,543

44,007

-13,097

-17,158

-73,090

-144,712

-5,258

-100,232

0

0

0